Acquisitions help boost Alere's 2012 Q4 revenue

Alere ($ALR) says its fourth quarter 2012 net revenue surged to nearly $756 million, up substantially from $651 million over the same period in 2011. A big part of that jump came from acquisitions in the diagnostics space, Alere said, which added nearly $78 million to the company's fourth-quarter revenue versus a year ago. The maker of diagnostics and health information products lost $62.7 million during the quarter, but that's down from a nearly $364 million net loss over its 2011 fourth quarter. Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.